A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy
A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy
Not yet recruiting · NCT07752264 · Registry updated 2026-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy | Refractory Immune-mediated Necrotizing Myopathy | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-07 | NCT07752264 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanjing IASO Biotechnology Co., Ltd. | 14 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China-Japan Friendship Hospital | Beijing | China | 81 |
| Huashan Hospital of Fudan University | Shanghai | China | 7 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 125 |
| The Second Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou | China | 31 |